SMN2 and proximal spinal muscular atrophy: The systemic administration of IPLEX (recombinant human IGF-1 complexed with recombinant human IGF-1 binding protein 3) by intraperitoneal injection in Smn−/−;SMN2;Δ7 animals led to increased myofiber size, reduced motor neuron cell loss but did not impact on life span and body weight of SMA model mice (Murdocca et al., 2012).